Sidharth Sonthalia
Research Subjects
Sidharth Sonthalia has a total of 189 co-authors. Here are the top co-authors by number of shared publications:
- Abhijeet Kumar Jha
Department of Dermatology & STD, Patna Medical College & Hospital, Patna, India
16 shared publications - Archana Singal
Department of Dermatology & STD, University College of Medical Sciences & GTB Hospital, Delhi, India
12 shared publications Mahima Agrawal
Department of Dermatology and STD, Lady Hardinge Medical College and Associated Hospital, Delhi, India
11 shared publicationsRahul Arora
Department of Dermatology, University College of Medical Sciences, Shahdara, New Delhi, India
10 shared publicationsRashmi Sarkar
Department of Dermatology, Maulana Azad Medical College, New Delhi, India
10 shared publicationsAimilios Lallas
First Department of Dermatology, Aristotle University, Thessaloniki, Greece
9 shared publications
Latest Publications
- 1 May 2023
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 88 (5) , e275-e276
An office-based evaluation of various itraconazole brands
- 1 May 2023
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 88 (5) , e275-e276
An office-based evaluation of various itraconazole brands
- Open Access
- 1 January 2022
- Published by Medknow in Indian Journal of Sexually Transmitted Diseases and AIDS
- Vol. 43 (1) , 104-105
Genital lichen planus
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic Society
- 1 January 2022
- Published by Medknow in Indian Journal of Sexually Transmitted Diseases and AIDS
- Vol. 43 (1) , 104-105
Open AccessGenital lichen planus
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic Society
- 11 May 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (7) , 2141-2147
Topical Band‐pass Filter Cream (TBFC)‐assisted home‐based NB‐UVB: A must‐know Alternative to artificial phototherapy
Background Treatment‐refractory lesions of vitiligo, and psoriasis are typically associated with significant psychological morbidity. Although narrow band‐ultra violet B (NB‐UVB) phototherapy remains one of the safest and effective treatment modalities, the cost and logistics related to the access and high‐cost of therapy delivered artificially via devices/chambers becomes highly restrictive. The use of topical Photocil®, a novel topical band‐pass filter cream (TBFC), that selectively filters solar radiation, biasing towards delivery of 311‐313 nm (action spectrum of NB‐UVB) to the treated lesions, following the exposure of TBFC‐smeared lesions to natural sunlight offsets many aforementioned limitations of artificial phototherapy. The non‐inferior efficacy of Photocil® as an alternative to artificial NB‐UVB has recently been reported in patients with lighter skin phototypes (SPT) with non‐segmental vitiligo and psoriasis. Objectives To demonstrate the high efficacy‐cum‐safety of the novel approach in repigmenting treatment‐refractory segmental vitiligo (SV) in an adult man with SPT‐V, and discuss the essentials of successful administration of NB‐UVB using this approach. Methods The baseline clinical details, and therapeutic outcome of 12‐week protocol of TBFC‐assisted NB‐UVB (with details of step‐by‐step administration including precautions) in SV of the aforementioned patient are discussed. Results Upto 75% repigmentation without any remarkable adverse effects was noted with persistent of efficacy over next 12 weeks. Conclusion The device‐free home‐based TBFC‐assisted NB‐UVB delivery using natural sunlight offers a viable, convenient and cost‐effective alternative to artificial phototherapy for successful treatment of vitiligo; with its utility proven even in SV that too in individual(s) with darker SPT.
- 11 May 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (7) , 2141-2147
Topical Band‐pass Filter Cream (TBFC)‐assisted home‐based NB‐UVB: A must‐know Alternative to artificial phototherapy
Background Treatment‐refractory lesions of vitiligo, and psoriasis are typically associated with significant psychological morbidity. Although narrow band‐ultra violet B (NB‐UVB) phototherapy remains one of the safest and effective treatment modalities, the cost and logistics related to the access and high‐cost of therapy delivered artificially via devices/chambers becomes highly restrictive. The use of topical Photocil®, a novel topical band‐pass filter cream (TBFC), that selectively filters solar radiation, biasing towards delivery of 311‐313 nm (action spectrum of NB‐UVB) to the treated lesions, following the exposure of TBFC‐smeared lesions to natural sunlight offsets many aforementioned limitations of artificial phototherapy. The non‐inferior efficacy of Photocil® as an alternative to artificial NB‐UVB has recently been reported in patients with lighter skin phototypes (SPT) with non‐segmental vitiligo and psoriasis. Objectives To demonstrate the high efficacy‐cum‐safety of the novel approach in repigmenting treatment‐refractory segmental vitiligo (SV) in an adult man with SPT‐V, and discuss the essentials of successful administration of NB‐UVB using this approach. Methods The baseline clinical details, and therapeutic outcome of 12‐week protocol of TBFC‐assisted NB‐UVB (with details of step‐by‐step administration including precautions) in SV of the aforementioned patient are discussed. Results Upto 75% repigmentation without any remarkable adverse effects was noted with persistent of efficacy over next 12 weeks. Conclusion The device‐free home‐based TBFC‐assisted NB‐UVB delivery using natural sunlight offers a viable, convenient and cost‐effective alternative to artificial phototherapy for successful treatment of vitiligo; with its utility proven even in SV that too in individual(s) with darker SPT.
- 24 April 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (3) , 1154-1162
Do oxidative stress and melanin accumulation contribute to the pathogenesis of idiopathic guttate hypomelanosis: A prospective case‐control study
Background: Oxidative stress parameters have been reported to be significantly higher than controls in diverse disorders of pigmentation but no such data seem to be extant for IGH.Objectives: To verify whether heightened oxidative stress levels are seen in patients with IGH (compared with matched controls) and quantify the same in blood using appropriate biochemical markers. Further, an attempt to determine if there might be any correlation between the amount of oxidative stress and the severity of the disease.Methodology: This prospective case‐control study was conducted in Northern India. Thirty Indian patients (Fitzpatrick skin phototype (SPT) IV‐V) were included. The diagnosis of IGH lesions was confirmed based on characteristic clinical, and dermoscopic characteristics and confirmed on histopathological examination (H & E) of one of the lesions.Results: The oxidative stress enzyme level was significantly higher among the cases compared to controls which were statistically significant (p < 0.05). A positive correlation was also observed between the levels of these markers and number of lesions, but this finding was statistically not significant [p > 0.05]. Assessment of melanin level by Dopa staining method in the IGH lesions revealed irregularly distributed melanin with areas of high and low melanin content and greater accumulation in the basement layer.Conclusion: The results of this probably the first study evaluating oxidative stress in IGH show that the oxidative stress is increased in patients with IGH. Level of oxidative stress seems to be correlated with both age of the patient (more in the elderly) and number of lesions.
- 24 April 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (3) , 1154-1162
Do oxidative stress and melanin accumulation contribute to the pathogenesis of idiopathic guttate hypomelanosis: A prospective case‐control study
Background: Oxidative stress parameters have been reported to be significantly higher than controls in diverse disorders of pigmentation but no such data seem to be extant for IGH.Objectives: To verify whether heightened oxidative stress levels are seen in patients with IGH (compared with matched controls) and quantify the same in blood using appropriate biochemical markers. Further, an attempt to determine if there might be any correlation between the amount of oxidative stress and the severity of the disease.Methodology: This prospective case‐control study was conducted in Northern India. Thirty Indian patients (Fitzpatrick skin phototype (SPT) IV‐V) were included. The diagnosis of IGH lesions was confirmed based on characteristic clinical, and dermoscopic characteristics and confirmed on histopathological examination (H & E) of one of the lesions.Results: The oxidative stress enzyme level was significantly higher among the cases compared to controls which were statistically significant (p < 0.05). A positive correlation was also observed between the levels of these markers and number of lesions, but this finding was statistically not significant [p > 0.05]. Assessment of melanin level by Dopa staining method in the IGH lesions revealed irregularly distributed melanin with areas of high and low melanin content and greater accumulation in the basement layer.Conclusion: The results of this probably the first study evaluating oxidative stress in IGH show that the oxidative stress is increased in patients with IGH. Level of oxidative stress seems to be correlated with both age of the patient (more in the elderly) and number of lesions.
- Open Access
- 15 April 2021
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (4) , e14959
“Azole menace”‐An underappreciated trigger perpetuating the epidemic of antifungal therapeutic failure in cutaneous mycoses
The South‐Asian epidemic of anti‐fungal therapeutic failures (AFTF) is on the rise. Although many demographic, environmental, and socioeconomic factors have been implicated in the genesis of this problem, two pharmacological issues warrant attention. While detailed discussions on the role of topical corticosteroid (TCS) in the changing landscape of the superficial mycotic infections in this region have been making headlines, another equally, rather more important pharmacological factor seems to have been undermined by the hype around TCS. The fastidious pharmacokinetic properties and related practical aspects of the triazole group of oral and topical antifungals, especially oral itraconazole seem to contribute significantly to the persistence of AFTF epidemic. In this paper, we shall discuss the broad aspects of the spectral precariousness of oral triazole antifungals with special emphasis to itraconazole, a concept known as the “azole menace” in the overall pathogenesis and tenacity of the AFTF epidemic.
- 15 April 2021
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (4) , e14959
Open Access“Azole menace”‐An underappreciated trigger perpetuating the epidemic of antifungal therapeutic failure in cutaneous mycoses
The South‐Asian epidemic of anti‐fungal therapeutic failures (AFTF) is on the rise. Although many demographic, environmental, and socioeconomic factors have been implicated in the genesis of this problem, two pharmacological issues warrant attention. While detailed discussions on the role of topical corticosteroid (TCS) in the changing landscape of the superficial mycotic infections in this region have been making headlines, another equally, rather more important pharmacological factor seems to have been undermined by the hype around TCS. The fastidious pharmacokinetic properties and related practical aspects of the triazole group of oral and topical antifungals, especially oral itraconazole seem to contribute significantly to the persistence of AFTF epidemic. In this paper, we shall discuss the broad aspects of the spectral precariousness of oral triazole antifungals with special emphasis to itraconazole, a concept known as the “azole menace” in the overall pathogenesis and tenacity of the AFTF epidemic.
- Open Access
- 1 January 2021
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 12 (1) , 203-205
Dermoscopy of Macular Amyloidosis
Indian Dermatol Online J, Official publication of IADVL
- 1 January 2021
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 12 (1) , 203-205
Open AccessDermoscopy of Macular Amyloidosis
Indian Dermatol Online J, Official publication of IADVL
- 1 November 2020
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 83 (5) , e341-e343
High-magnification universal serial bus dermoscopy: A convenient alternative to direct microscopic examination
- 1 November 2020
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 83 (5) , e341-e343
High-magnification universal serial bus dermoscopy: A convenient alternative to direct microscopic examination
- 31 October 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (1) , e14478
Application of mucous membrane dermoscopy (mucoscopy) in diagnostics of benign oral lesions ‐ literature review and preliminary observations from International Dermoscopy Society study
Dermoscopy of mucosal surface termed ‘mucoscopy’ is an upcoming offshoot of dermatological imaging. However, the literature on mucoscopy is limited to individual cases and small case series. An organized review or systematic analysis of mucoscopy is lacking. The aim of this review was to summarize the published literature on mucoscopic features of benign conditions affecting the oral mucosa and semi‐mucosa. Additionally, the results of mucoscopic features of diseases, which have not been described before has been presented.
- 31 October 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (1) , e14478
Application of mucous membrane dermoscopy (mucoscopy) in diagnostics of benign oral lesions ‐ literature review and preliminary observations from International Dermoscopy Society study
Dermoscopy of mucosal surface termed ‘mucoscopy’ is an upcoming offshoot of dermatological imaging. However, the literature on mucoscopy is limited to individual cases and small case series. An organized review or systematic analysis of mucoscopy is lacking. The aim of this review was to summarize the published literature on mucoscopic features of benign conditions affecting the oral mucosa and semi‐mucosa. Additionally, the results of mucoscopic features of diseases, which have not been described before has been presented.
- 4 July 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (6) , e13954
A comparative study of topical tacrolimus and topical triamcinolone acetonide in nodular scabies
Objective The aim of this study was to compare the efficacy and safety of 0.1% triamcinolone acetonide and 0.1% tacrolimus ointment for the treatment of such nodular lesions of scabies. Methods In this double‐blind randomized controlled trial, fifty Indian men with postscabeitic persistent nodular lesions over the external genitalia, were enrolled. They were randomized into two groups to receive either triamcinolone acetonide 0.1% ointment twice daily, or tacrolimus ointment 0.03% twice daily over the nodular lesions for 2 weeks. All patients were followed up on three visits: 1, 2, and 6 weeks, for assessment. Efficacy was evaluated by 5‐point range investigator‐assessed VAS, and a 4‐point severity of pruritus scale (SPS) score. Results The mean VAS score was higher in triamcinolone group compared to tacrolimus group at both follow ups, although statistically significant only at 2nd week visit. The fall in mean SPS at both follow ups was higher in the steroid group, but the difference was not statistically significant. Discussion Although both treatment options provided satisfactory short term improvement, triamcinolone ointment proved to be more efficacious. Conclusions Mid‐potency TCS are more effective in treatment of nodular lesions of NS/PSP. Topical CNIs may be considered if prolonged topical therapy is warranted.
- 4 July 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (6) , e13954
A comparative study of topical tacrolimus and topical triamcinolone acetonide in nodular scabies
Objective The aim of this study was to compare the efficacy and safety of 0.1% triamcinolone acetonide and 0.1% tacrolimus ointment for the treatment of such nodular lesions of scabies. Methods In this double‐blind randomized controlled trial, fifty Indian men with postscabeitic persistent nodular lesions over the external genitalia, were enrolled. They were randomized into two groups to receive either triamcinolone acetonide 0.1% ointment twice daily, or tacrolimus ointment 0.03% twice daily over the nodular lesions for 2 weeks. All patients were followed up on three visits: 1, 2, and 6 weeks, for assessment. Efficacy was evaluated by 5‐point range investigator‐assessed VAS, and a 4‐point severity of pruritus scale (SPS) score. Results The mean VAS score was higher in triamcinolone group compared to tacrolimus group at both follow ups, although statistically significant only at 2nd week visit. The fall in mean SPS at both follow ups was higher in the steroid group, but the difference was not statistically significant. Discussion Although both treatment options provided satisfactory short term improvement, triamcinolone ointment proved to be more efficacious. Conclusions Mid‐potency TCS are more effective in treatment of nodular lesions of NS/PSP. Topical CNIs may be considered if prolonged topical therapy is warranted.
- 30 May 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (6) , e13735
Intramatricial platelet‐rich plasma in nail disorders: Amending the methodological omissions and unethical commissions
- 30 May 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (6) , e13735
Intramatricial platelet‐rich plasma in nail disorders: Amending the methodological omissions and unethical commissions